Literature DB >> 23228292

Ureteroscopic biopsy of upper tract urothelial carcinoma using a novel ureteroscopic biopsy forceps.

Shaun E L Wason1, John D Seigne, Alan R Schned, Vernon M Pais.   

Abstract

INTRODUCTION: We sought to assess the adequacy of surgical specimens obtained utilizing the BIGopsy (Cook Medical, Bloomington, IN, USA) biopsy forceps both ex vivo and in vivo and compare them to traditional 3Fr biopsy forceps in patients with suspected upper tract urothelial carcinoma.
MATERIALS AND METHODS: Patients undergoing nephroureterectomy for suspected upper tract transitional cell carcinoma were recruited. Surgical specimens, immediately after extirpation were examined and alternatively biopsied ex vivo with the BIGopsy and 3Fr biopsy forceps. We then retrospectively reviewed our most recent experience with ureteroscopic biopsy. The biopsy device, size, depth, grade, stage, pathologic diagnosis and subjective biopsy quality were assessed.
RESULTS: Three ex vivo nephroureterectomy specimens were evaluated. The average biopsy size from the 3Fr biopsy forceps was 3.5 +/- 2.8 mm2 and for the BIGopsy was 31.2 +/- 34.6 mm2. Subjectively, the BIGopsy specimens revealed less distortion and fragmentation and were easier to interpret by the pathologist. Sixteen patients underwent 19 ureteroscopic procedures. The mean size in maximal diameter (mm +/- SD) of the biopsies in each group were; 3Fr 1.2 +/- 0.4, BIGopsy 3.4 +/- 2.0, nitinol basket 4.9 +/- 4.0 and laser 11 +/- 8.5. Lamina propria was identified in 3/13 (23%) biopsies with 3Fr biopsy forceps, 6/11 (55%) biopsies with the BIGopsy forceps, 6/8 (75%) biopsies with the nitinol basket and 2/2 (100%) biopsies with the holmium laser. Six patients underwent biopsies with both the BIGopsy and 3Fr biopsy forceps. A definitive diagnosis was made in 2/6 cases with the 3Fr biopsy forceps compared with all 6/6 cases with the BIGopsy biopsy forceps. Grade and stage matched final surgical grade and stage in 3/3 cases biopsied with the BIGopsy.
CONCLUSION: For lesions with stalks, the holmium laser and basket biopsy provided larger specimens than either of the forceps. For flat or sessile lesions, the BIGopsy biopsy forceps provided larger, deeper less distorted specimens than the 3Fr biopsy forceps and correlated well with ultimate grade and stage. Improved biopsy quality may translate into improved ability to diagnose both benign and malignant ureteral and renal pelvic mucosal lesions endoscopically.

Entities:  

Mesh:

Year:  2012        PMID: 23228292

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  8 in total

1.  Optimizing RNA Extraction of Renal Papilla Biopsy Tissue in Kidney Stone Formers: A New Methodology for Genomic Study.

Authors:  Kazumi Taguchi; Manint Usawachintachit; Shuzo Hamamoto; Rei Unno; David T Tzou; Benjamin A Sherer; Yongmei Wang; Atsushi Okada; Marshall L Stoller; Takahiro Yasui; Thomas Chi
Journal:  J Endourol       Date:  2017-08-11       Impact factor: 2.942

2.  Superiority of the EF-120-00-3F biopsy forceps in the histopathological evaluation of upper urinary tract specimens.

Authors:  Mario W Kramer; Mahmoud Abbas; Mohammad Kabbani; Florian Imkamp; Udo Nagele; Thorsten Bach; Stephan Jutzi; Christoph von Klot; Jan Becker; Axel S Merseburger; Markus A Kuczyk; Hans H Kreipe; Thomas R Herrmann
Journal:  World J Urol       Date:  2013-12-17       Impact factor: 4.226

3.  A Novel Technique to Improve the Processing of Minute Ureteroscopic Biopsies.

Authors:  Shay Golan; Glenn Gerber; David Margel; Lea Rath-Wolfson; Yaron Ehrlich; Rumelia Koren; David Lifshitz
Journal:  Pathol Oncol Res       Date:  2017-04-03       Impact factor: 3.201

Review 4.  Disposable devices for RIRS: where do we stand in 2013? What do we need in the future?

Authors:  Richard H Shin; Michael E Lipkin; Glenn M Preminger
Journal:  World J Urol       Date:  2014-07-30       Impact factor: 4.226

Review 5.  Endoscopic Treatment of Upper Tract Urothelial Carcinoma.

Authors:  Daniel P Verges; Costas D Lallas; Scott G Hubosky; Demetrius H Bagley
Journal:  Curr Urol Rep       Date:  2017-04       Impact factor: 3.092

Review 6.  Pushing the boundaries of ureteroscopy: current status and future perspectives.

Authors:  Petrisor Geavlete; Razvan Multescu; Bogdan Geavlete
Journal:  Nat Rev Urol       Date:  2014-06-03       Impact factor: 14.432

7.  Multi-institutional Evaluation of Upper Urinary Tract Biopsy Using Backloaded Cup Biopsy Forceps, a Nitinol Basket, and Standard Cup Biopsy Forceps.

Authors:  Daniel J Lama; Shoaib Safiullah; Roshan M Patel; Thomas K Lee; Jyoti P Balani; Lishi Zhang; Zhamshid Okhunov; Vitaly Margulis; Stephen J Savage; Edward Uchio; Jaime Landman
Journal:  Urology       Date:  2018-04-06       Impact factor: 2.649

8.  Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers.

Authors:  Angela Gillan; Ismail El-Mokadem; Bhavan Rai; Stephen Lang; Jason Alcorn; Altaf Shams Ud Din; Ranan Dasgupta; Chandra Shekhar Biyani; Ghulam Nabi
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.